RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/11116209http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/11116209http://www.w3.org/2000/01/rdf-schema#comment"We have studied the effects of a cardiac sparing thyromimetic, CGS 23425, on postprandial levels of triglycerides, abundance of apolipoprotein B (apo B) protein and hepatic apo B mRNA expression in rats. When compared with control rats, triglyceride clearance was significantly accelerated by treatment with CGS 23425. A full return to baseline values was achieved within 8 h after ingesting a large quantity of fat, as compared to >24 h in control animals. The abundance of apo B-100 protein in CGS 23425-treated hyperlipidemic rats decreased in a dose-dependent manner, but levels of apo B-48 were not significantly affected. Like L-tri-iodothyronine (L-T(3)), treatment with 30 microg/kg CGS 23425 for 6 or 9 days decreased the levels of apo B-100 protein by 80% and 40% respectively. This change was paralleled by a 27% reduction in hepatic apo B-100 mRNA. To investigate a potential mechanism of CGS 23425 action, we measured in vitro apo B mRNA editing activity in hepatocellular extract from control or CGS 23425-treated rats. Treatment with CGS 23425 increased activity of the hepatic apo B-100 editosome, apobec-1. In human hepatoma cells which lack apobec-1 activity, apo B-100 mRNA levels remained the same in cells treated with or without the agent. In summary, these observations show that CGS 23425 decreases the levels of apo B-100 in rats. This action of CGS 23425 involves apo B-100 mRNA editing activity."xsd:string
http://purl.uniprot.org/citations/11116209http://purl.org/dc/terms/identifier"doi:10.1677/jme.0.0250299"xsd:string
http://purl.uniprot.org/citations/11116209http://purl.uniprot.org/core/author"Steele R.E."xsd:string
http://purl.uniprot.org/citations/11116209http://purl.uniprot.org/core/author"Wada Y."xsd:string
http://purl.uniprot.org/citations/11116209http://purl.uniprot.org/core/author"Dufresne J."xsd:string
http://purl.uniprot.org/citations/11116209http://purl.uniprot.org/core/author"Matsubara S."xsd:string
http://purl.uniprot.org/citations/11116209http://purl.uniprot.org/core/author"Wong N.C."xsd:string
http://purl.uniprot.org/citations/11116209http://purl.uniprot.org/core/author"Hargrove G.M."xsd:string
http://purl.uniprot.org/citations/11116209http://purl.uniprot.org/core/author"Stephan Z.F."xsd:string
http://purl.uniprot.org/citations/11116209http://purl.uniprot.org/core/date"2000"xsd:gYear
http://purl.uniprot.org/citations/11116209http://purl.uniprot.org/core/name"J Mol Endocrinol"xsd:string
http://purl.uniprot.org/citations/11116209http://purl.uniprot.org/core/pages"299-308"xsd:string
http://purl.uniprot.org/citations/11116209http://purl.uniprot.org/core/title"Effects of a thyromimetic on apolipoprotein B-100 in rats."xsd:string
http://purl.uniprot.org/citations/11116209http://purl.uniprot.org/core/volume"25"xsd:string
http://purl.uniprot.org/citations/11116209http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/11116209
http://purl.uniprot.org/citations/11116209http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/11116209
http://purl.uniprot.org/uniprot/P38483#attribution-4D59EEB4B03DC172DB9B9E77D8C7B091http://purl.uniprot.org/core/sourcehttp://purl.uniprot.org/citations/11116209
http://purl.uniprot.org/uniprot/#_A0A8I6B1D0-mappedCitation-11116209http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/11116209
http://purl.uniprot.org/uniprot/#_A0A8L2QAE9-mappedCitation-11116209http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/11116209
http://purl.uniprot.org/uniprot/#_A0A8I5Y1P0-mappedCitation-11116209http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/11116209
http://purl.uniprot.org/uniprot/#_A0A8I5Y2I8-mappedCitation-11116209http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/11116209
http://purl.uniprot.org/uniprot/#_P38483-mappedCitation-11116209http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/11116209
http://purl.uniprot.org/uniprot/A0A8L2QAE9http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/11116209
http://purl.uniprot.org/uniprot/P38483http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/11116209